论文部分内容阅读
1997年 9月～ 11月 ,受北京第二制药厂委托 ,由中华医学会上海分会组织本市七家医疗单位 (中山、华山、瑞金、仁济、市一、市六和静安区中心医院 )对该厂生产的马沙尼片 (盐酸特拉唑嗪片 )进行良性前列腺增生症治疗的多中心开放式临床验证 ,重点观察其有效性及安全性 ,现将有关
From September 1997 to November 1997, commissioned by Beijing No. 2 Pharmaceutical Factory, Shanghai Medical Association Shanghai Branch organized seven medical units (Zhongshan, Huashan, Ruijin, Renji, Liuyi and Jing’an District Central Hospital) Multisite open-center clinical validation of the plant-produced Masanic tablets (terazosin hydrochloride tablets) for the treatment of benign prostatic hyperplasia, with emphasis on its efficacy and safety, will now be relevant